Impact of nutritional status in the era of FOLFOX/FIRI-based chemotherapy

por Okada, Shunji, Yamazaki, Shintaro, Kaiga, Teruo, Funada, Tomoya, Kochi, Mitsugu, Takayama, Tadatoshi
Publicado 2017

Addition of docetaxel to S-1 results in significantly superior 5-year survival outcomes in Stage III gastric cancer: a final report of the JACCRO GC-07 study

por Kodera, Yasuhiro, Yoshida, Kazuhiro, Kochi, Mitsugu, Sano, Takeshi, Ichikawa, Wataru, Kakeji, Yoshihiro, Sunakawa, Yu, Takeuchi, Masahiro, Fujii, Masashi
Publicado 2023

A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report

por Matsuno, Yoritaka, Kochi, Mitsugu, Fujii, Masashi, Kanamori, Noriaki, Kaiga, Teruo, Mihara, Yoshiaki, Funada, Tomoya, Miyazaki, Teruyuki, Takayama, Tadatoshi
Publicado 2012

Malignant Peritoneal Mesothelioma Mimicking Ischemic Colitis

por Mitsuka, Yuusuke, Yamazaki, Shintaro, Miyakuni, Taiki, Iwama, Atsuko, Funada, Tomoya, Watanabe, Yoshifumi, Kaiga, Teruo, Okada, Shunji, Kochi, Mitsugu, Takayama, Tadatoshi
Publicado 2010

Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes

por Kochi, Mitsugu, Fujii, Masashi, Masuda, Shinobu, Kanamori, Noriaki, Mihara, Yoshiaki, Funada, Tomoya, Tamegai, Hidenori, Watanabe, Megumu, Suda, Hiroshi, Takayama, Tadatoshi
Publicado 2013

Human epidermal growth factor 2 overexpressed alpha-fetoprotein-producing-gastric cancer

por Shimizu, Hiroko, Kochi, Mitsugu, Fujii, Masashi, Watabe, Megumu, Matsuno, Yoritaka, Kawai, Takaharu, Suda, Hiroshi, Tanino, Tomoyuki, Nakanishi, Yoko, Masuda, Shinobu, Okamura, Yukiyasu
Publicado 2023

Laparoscopic-assisted modified Kugel herniorrhaphy for obturator hernia: a case report

por Yamagishi, Shunsuke, Aramaki, Osamu, Yoshida, Nao, Mitsuka, Yusuke, Kawai, Takaharu, Yamazaki, Shintaro, Kang, Woodae, Nakayama, Hisashi, Moriguchi, Masamichi, Higaki, Tokio, Kochi, Mitsugu, Okamura, Yukiyasu
Publicado 2022

A multicenter, open-label, single-arm phase I trial of neoadjuvant nivolumab monotherapy for resectable gastric cancer

por Hasegawa, Hirotaka, Shitara, Kohei, Takiguchi, Shuji, Takiguchi, Noriaki, Ito, Seiji, Kochi, Mitsugu, Horinouchi, Hidehito, Kinoshita, Takahiro, Yoshikawa, Takaki, Muro, Kei, Nishikawa, Hiroyoshi, Suna, Hideaki, Kodera, Yasuhiro
Publicado 2022

Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial

por Yoshida, Kazuhiro, Kodera, Yasuhiro, Kochi, Mitsugu, Ichikawa, Wataru, Kakeji, Yoshihiro, Sano, Takeshi, Nagao, Narutoshi, Takahashi, Masazumi, Takagane, Akinori, Watanabe, Takuya, Kaji, Masahide, Okitsu, Hiroshi, Nomura, Takashi, Matsui, Takanori, Yoshikawa, Takaki, Matsuyama, Jin, Yamada, Makoto, Ito, Seiji, Takeuchi, Masahiro, Fujii, Masashi
Publicado 2019

Phase 2 study of irinotecan plus cetuximab rechallenge as third-line treatment in KRAS wild-type metastatic colorectal cancer: JACCRO CC-08

por Masuishi, Toshiki, Tsuji, Akihito, Kotaka, Masahito, Nakamura, Masato, Kochi, Mitsugu, Takagane, Akinori, Shimada, Ken, Denda, Tadamichi, Segawa, Yoshihiko, Tanioka, Hiroaki, Hara, Hiroki, Sagawa, Tamotsu, Watanabe, Takanori, Takahashi, Takao, Negoro, Yuji, Manaka, Dai, Fujita, Hideto, Suto, Takeshi, Takeuchi, Masahiro, Ichikawa, Wataru, Fujii, Masashi
Publicado 2020